Results 71 to 80 of about 180,701 (284)

Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong.

, 2003
BACKGROUND: Health authorities worldwide, especially in the Asia Pacific region, are seeking effective public-health interventions in the continuing epidemic of severe acute respiratory syndrome (SARS).
Abu-Raddad, Laith J, Anderson, Roy M, Chan, King-Pan, Chau, Patsy, Donnelly, Christl A, Ferguson, Neil M, Fraser, Christophe, Ghani, Azra C, Hedley, Anthony J, Ho, Lai-Ming, Kong, James HB, Lam, Tai-Hing, Lau, Edith MC, Leung, Gabriel M, Liu, Shao-Haei, Riley, Steven, Thach, Thuan-Quoc, Tsang, Thomas, Tse, Lai-Yin   +18 more
core   +1 more source

Retrained Generic Antibodies Can Recognize SARS-CoV-2 [PDF]

The Journal of Physical Chemistry Letters, 2020
The dramatic impact which novel viruses can have on the human society could be mitigated without the need of vaccination if antibodies present within the population are retrained to recognize these viruses. With this idea in mind, a double-faced peptide-based boosters are computationally designed to allow recognition of SARS-CoV-2 by Hepatitis B ...
Han, Yanxiao, McReynolds, Katherine D., Král, Petr   +2 more
openaire   +3 more sources

COVID‐19 Vaccination is not Associated with the Development of Idiopathic Inflammatory Myositis in U.S. Veterans

Arthritis Care &Research, Accepted Article.
Objective Several case reports have proposed a potential association between COVID‐19 vaccination and the subsequent development of idiopathic inflammatory myositis (IIM). This study examined prior COVID‐19 vaccination in US Veterans who developed new‐onset IIM compared to those without new‐onset IIM.
Caleb Hernández, Naomi Schlesinger, Jorge Rojas, Jessica A. Walsh, Tawnie J Braaten, Gary A Kunkel, Makoto Jones, Brian C Sauer, Julio Facelli, Grant W. Cannon, Dorota Lebiedz‐Odrobina   +10 more
wiley   +1 more source

Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS [PDF]

, 2016
1. Anti-SARS-CoV spike antibodies promote infection of primary human immune cells by SARS-CoV. 2. The antibody-dependent enhancement (ADE) infection pathway grants SARS-CoV an opportunity to infect primary human macrophages, but it does not sustain ...
Bruzzone, R, Cheung, CY, Daëron, M, Dutry, ICA, Jaume, MDA, LEUNG, HL, Li, D, Li, PH, Peiris, JSM, Yip, MS   +9 more
core  

Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions.

, 2003
We present an analysis of the first 10 weeks of the severe acute respiratory syndrome (SARS) epidemic in Hong Kong. The epidemic to date has been characterized by two large clusters-initiated by two separate "super-spread" events (SSEs)-and by ongoing ...
Abu-Raddad, Laith J, Anderson, Roy M, Chan, King-Pan, Chau, Patsy, Donnelly, Christl A, Ferguson, Neil M, Fraser, Christophe, Ghani, Azra C, Hedley, Anthony J, Ho, Lai-Ming, Ho, William, Lam, Tai-Hing, Lau, Edith MC, Lee, Koon-Hung, Leung, Gabriel M, Leung, Pak-Yin, Lo, Su-Vui, Riley, Steven, Thach, Thuan Q, Tsang, Thomas   +19 more
core   +1 more source

A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) [PDF]

, 2019
Background The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) was first described in 2012 and attracted a great international attention due to multiple healthcare associated outbreaks.
Al-Ali, Anfal Y., Al-Tawfiq, Jaffar A., Momattin, Hisham   +2 more
core   +1 more source

SnapShot: SARS-CoV-2 antibodies [PDF]

Cell Host & Microbe, 2021
Montefiori, David C., Acharya, Priyamvada   +1 more
openaire   +2 more sources

Combinatorial Synthesis of Next Generation Water‐Soluble Quaternized N‐Halamine Oligomers with Long‐Lasting Antiviral Properties

Advanced Functional Materials, EarlyView.
A combinatorial library of dual‐functional antiviral oligomers incorporating N‐halamine and quaternary ammonium functionalities is developed for long‐lasting antiviral activity. The lead materials exhibit rapid and durable antiviral activity against SARS‐CoV‐2 variants and influenza H1N1, with 4 to 5 log reduction in viral copies at 5 mg mL−1 ...
Eid Nassar‐Marjiya, Konda Reddy Kunduru, Krishanu Ghosal, Luna Rizik, Nofar Atari, Mahran Daifa, Neta Kutner, Bassma Khamaisi, Qi Wu, Simran Jindal, Merna Shaheen‐Mualim, Ranabir Majumder, Mahitosh Mandal, Michal Mandelboim, Shady Farah   +14 more
wiley   +1 more source

Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain

Human Vaccines & Immunotherapeutics, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) variants have been reported to be resistant to several neutralizing antibodies (NAbs) targeting Receptor Binding Domain (RBD) and N Terminal Domain (NTD) of spike (S) protein and thus inducing ...
Xingsu Gao, Linlin Fan, Binyang Zheng, Haoze Li, Jiwei Wang, Li Zhang, Jingxin Li, Fengcai Zhu   +7 more
doaj   +1 more source

Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department [PDF]

, 2020
As of March 30th, 2020 there were 161,807 total cases and 2,953 total deaths of SARS-CoV-2 in the United States, with the number of cases expected to rise.
Brown, Cortlyn, Coralic, Zlatan, Noble, Jeanne   +2 more
core